Related Experiment Video

Updated: Sep 13, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

548

Revolutionizing cancer treatment: Exploring novel immunotherapeutics, checkpoints, bispecifics, and vaccines in

Anas Islam1, Vijay Singh2, Pooja S Murkute3

  • 1Faculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh, India.

Advances in Immunology
|July 30, 2025
PubMed

Insights

Innovative immunotherapies, including immune checkpoint inhibitors, bispecific antibodies, and cancer vaccines, are revolutionizing cancer treatment. These advanced therapies offer new hope for transforming patient outcomes in oncology.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Current cancer treatments face limitations, necessitating novel therapeutic strategies.
  • The field of cancer treatment is rapidly evolving with new approaches.

Purpose of the Study:

  • To provide a comprehensive overview of innovative immunotherapies for cancer treatment.
  • To explore the principles, mechanisms, and applications of emerging cancer therapies.

Main Methods:

  • Review of current cancer treatment paradigms.
  • Exploration of immunotherapy principles and trends.
  • Analysis of immune checkpoint inhibitors, bispecific antibodies, and cancer vaccines.

Main Results:

  • Detailed examination of checkpoint blockade therapy mechanisms.
  • Discussion of bispecific antibodies' unique functions and challenges.
  • Overview of preventive, therapeutic, and personalized cancer vaccine development.

Conclusions:

  • Immunotherapy represents a significant advancement in cancer treatment.
  • Future directions in cancer immunotherapy hold potential for improved patient outcomes.
Keywords:
Bispecific antibodiesCancer therapyCancer vaccineClinical trialsImmunotherapyPersonalized medicine

More Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

800
Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.4K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
514
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K